ABSTRACT
Objective To analyze the current status of research competitiveness of medical subjects in China.Methods Analyzing the fund of Natural Science Foundation of China (NSFC) in 2017 and using the Range ratio and Theil Index to describe the dispersion and source of difference.Regional research competitiveness of Chinese medical subjects is measured by the attraction and accumulation capacity of NSFC.Results The research competitiveness of medical subjects in East China and South China are stronger,and those in the Northwest are weaker.The distribution of medical funds mainly originated from the interior (88.88％),among which the East China and North China are the two regions with the largest contribution rate.In terms of provinces,Shanghai and Beijing have a much higher concentration of medical funds than other provinces.Condusions The Research competitiveness in inter-regional medical subjects in China is quite different,and the differences mainly stem from the competition of internal provinces;the degree of advantages of medical subjects in regions is different,and there are medical research centers in ever regions.
ABSTRACT
The maturity and scientific research strength of medical subjects between PRC and India and between PRC and Japan were demonstrated by comparing the scale and production distribution of international papers authors between PRC and India and between PRC and Japan according to the SCADC(2011), SCIE, InCites Statistical Analysis Database, non-regression fitting curve, K-S Test and Rnew fitting goodness, which showed that SCADC(2011) and SCIE displayed 53 specific medical subjects.Lotka distribution and author scale analysis showed that the maturity and scientific research strength of tropical medicine and pediatrics were lower while those of drug abuse, combined traditional and western medicine, primary health care, medical informatics, parasitology, audiology, speech and language pathology were higher in PRC than in Japan.
ABSTRACT
Objective To evaluate the research performance based on DEA and to provide the corresponding development measures for medical subjects in hospital.Methods Based on the analysis of medical subjects at Peking University People's Hospital,this paper explored the evaluation index system of medical subjects.The output-oriented DEA was selected and applied in the performance evaluation.Results We figure out that the DEA ratio of every medical subject with the established method in the program of DEAP Version 2.1.Conclusions The method based on DEA can reflect the performance of medical subjects,and the analysis of the evaluation results can provide the management department of hospital with evidences and references for policy making of medical subjects' development.
ABSTRACT
Hirsch index or h-index of a subject means that the subject has h published papers which are cited at least h times for each.This index is considered as both quantity and quality of the SHbiect's academic outcome.In this paper the data showed that the h-indexes of the Chinese medical SUbiects were different.The SUbiect's h-index could be used as a balance factor.which made the outcome of scientists from different SUbiects comparable.Using h-index and the other 2 indexes.Chinese medical snbiects were clustered into 4 groups,which could be used as a guideline for classified management and the evaluation of the medical subjects